Novel films for drug delivery via the buccal mucosa using model soluble and insoluble drugs

Drug Development and Industrial Pharmacy

Volumn 38, Issue 10, 2012, Pages 1207-1220

  Kianfar, Farnoosh ^a   Chowdhry, Babur Z ^a   Antonijevic, Milan D ^a   Boateng, Joshua S ^a  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

Author keywords

Carrageenan; Indomethacin; Paracetamol; Physical characterization; Plasticizer; Solvent cast films; Tensile properties

Indexed keywords

CARRAGEENAN; INDOMETACIN; MACROGOL; PARACETAMOL; POLOXAMER;

ARTICLE; CHEEK MUCOSA; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; FILM; GEL; IN VITRO STUDY; SALIVA; SCANNING ELECTRON MICROSCOPY; SIMULATION; THERMOGRAVIMETRY; WATER CONTENT; X RAY POWDER DIFFRACTION;

ACETAMINOPHEN; CALORIMETRY, DIFFERENTIAL SCANNING; CARRAGEENAN; CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; INDOMETHACIN; MICROSCOPY, ELECTRON, SCANNING; MOUTH MUCOSA; POLOXAMER; POLYETHYLENE GLYCOLS; SALIVA; SOLUBILITY; WATER; X-RAY DIFFRACTION;

EID: 84866253076     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2011.644294     Document Type: Article

References (38)

1. Mathias NR, Hussain MA. (2010). Non-invasive systemic drug delivery: Developability considerations for alternate routes of administration. J Pharm Sci, 99:1-20.
2. Shojaei AH. (1998). Buccal mucosa as a route for systemic drug delivery: A review. J Pharm Pharm Sci, 1:15-30.
3. Asane GS, Nirmal SA, Rasal KB, Naik AA, Mahadik MS, Rao YM. (2008). Polymers for mucoadhesive drug delivery system: A current status. Drug Dev Ind Pharm, 34:1246-1266.
4. Bruschi ML, de Freitas O. (2005). Oral bioadhesive drug delivery systems. Drug Dev Ind Pharm, 31:293-310. (Pubitemid 40463973)
5. Squier CA, Wertz PW. (1993). Permeability and the pathophysiology of oral mucosa. Adv Drug Delivery Rev, 12:13-24. (Pubitemid 23332995)
6. Sohi H, Ahuja A, Ahmad FJ, Khar RK. (2010). Critical evaluation of permeation enhancers for oral mucosal drug delivery. Drug Dev Ind Pharm, 36:254-282.
7. Yehia SA, El-Gazayerly ON, Basalious EB. (2008). Design and in vitro/in vivo evaluation of novel mucoadhesive buccal discs of an antifungal drug: Relationship between swelling, erosion, and drug release. AAPS PharmSciTech, 9:1207-1217.
8. Birudaraj R, Mahalingam R, Li X, Jasti BR. (2005). Advances in buccal drug delivery. Crit Rev Ther Drug Carrier Syst, 22:295-330. (Pubitemid 41557320)
9. Wang B, Siahaan T, Soltero R. (2005). Drug delivery: Principles and applications Hoboken, New Jersey: Wiley-Interscience: 35-42.
10. Smart JD. (2005). Buccal drug delivery. Expert Opin Drug Deliv, 2:507-517. (Pubitemid 41683224)
11. Degim T, Eglen B, Ocak O. (2006). A sustained release dosage form of acyclovir for buccal application: An experimental study in dogs. J Drug Target, 14:35-44.
12. Sasaki S, Koumi S, Sato R, Murata M, Nagasawa K, Sakurai E et al. (1998). Kinetics of buccal absorption of propafenone single oral loading dose in healthy humans. Gen Pharmacol, 31:589-591. (Pubitemid 28458929)
13. Boateng JS, Auffret AD, Matthews KH, Humphrey MJ, Stevens HN, Eccleston GM. (2010). Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces. Int J Pharm, 389:24-31.
14. Pather SI, Rathbone MJ, Senel S. (2008). Current status and the future of buccal drug delivery systems. Expert Opin Drug Deliv, 5:531-542. (Pubitemid 351877432)
15. Salamat-Miller N, Chittchang M, Johnston TP. (2005). The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev, 57:1666-1691. (Pubitemid 41443474)
16. Yughuchi Y, Thuy TT, Urakawa H, Kajiwara K. (2002). Structural characteristics of carrageenan gels: Temperature and concentration dependence. Food Hydrocoll, 16:515-522. (Pubitemid 35177839)
17. Thommes M, Kleinebudde P. (2008). The behavior of different carrageenans in pelletization by extrusion/spheronization. Pharm Dev Technol, 13:27-35. (Pubitemid 351304465)
18. Rajput GC, Majmudar FD, Patel JK, Patel KN, Thakor RS, Patel BP, Rajgor NB. (2010). Stomach specific mucoadhesive tablets as controlled drug delivery system - A review work. Int J Pharm Bio Research, 1:30-41.
19. Kabanova AV, Batrakovaa EV, Alakhov VY. (2002). Pluronic® block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release, 82:189-212. (Pubitemid 34880178)
20. Dumortier G, Grossiord JL, Agnely F, Chaumeil JC. (2006). A review of poloxamer 407 pharmaceutical and pharmacological characteristics. Pharm Res, 23:2709-2728. (Pubitemid 44885361)
21. Craig DQM. (1995). A review of thermal methods used for the analysis of the crystal form, solution thermodynamics and glasstransition behaviour of polyethylene glycols. Thermochim Acta, 248:189-203.
22. Rosen MR. (2005). Delivery system handbook for personal care and cosmetic products: Technology, applications, and formulations. Norwich, UK: William Andrew Publishers, Inc. pp 120-124.
23. Boateng JS, Matthews KH, Stevens HN, Eccleston GM. (2008). Wound healing dressings and drug delivery systems: A review. J Pharm Sci, 97:2892-2923.
24. Gelcarinâ and Viscarinâ carrageenan, NF, Technical Bulletin online. Available at: www.avicel.com.
25. Alexandridis P, Hatton AT. (1995). Review: Poly (ethylene oxide)-poly (propylene oxide)-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: Thermodynamics, structure, dynamics, and modelling. Colloids Surf A Physicochem Eng Asp, 96:1-46.
26. Hancock BC, Parks M. (2000). What is the true solubility advantage for amorphous pharmaceuticals? Pharm Res, 17: 397-404. (Pubitemid 30395293)
27. Park K, Okano T, Ottenbrite M. (2010). Biomedical applications of hydrogels handbook. New York. Springer pp 1-3.
28. Zelkó R, Orbán A, Süvegh K, Riedl Z, Rácz I. (2002). Effect of plasticizer on the dynamic surface tension and the free volume of Eudragit systems. Int J Pharm, 244:81-86. (Pubitemid 35245448)
29. Boateng JS, Stevens HN, Eccleston GM, Auffret AD, Humphrey MJ, Matthews KH. (2009). Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces. Drug Dev Ind Pharm, 35:986-996.
30. Slade L, Levine H. (2003). Water and the glass transitiondependence of the glass transition on composition and chemical structure: Special implications for flour functionality in cookie baking. J Food Process Eng, 22:143-188.
31. Di Martino P, Guyot-Hermann AM, Conflant P, Drache M, Guyot J. (1996). New pure paracetamol for direct compression: Orthorhombic form. Int J Pharm, 128:1-8. (Pubitemid 26092142)
32. Boldyreva V, Drebushchak V, Yulia P, Drebushchak T. (2004). DSC and adiabatic calorimetry study of the polymorphs of PM. J Therm Anal Calorim, 77:607-623.
33. Bley H, Fussnegger B, Bodmeier R. (2010). Characterization and stability of solid dispersions based on PEG/polymer blends. Int J Pharm, 390:165-173.
34. Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722-1728. (Pubitemid 29530405)
35. Schmidta A, Wartewigb S, Picker K. (2003). Potential of carrageenans to protect drugs from polymorphic transformation. Eur J Pharm Biopharm, 56:101-110. (Pubitemid 36802053)
36. Mandal A.S, Chatterjee S, Karim K.M, Biswas N, Guha A, Behera M, Kuotsu K. (2011). Fabrication and in vitro evaluation of bidirectional release and stability studies of mucoadhesive donutshaped captopril tablets. Drug Dev Ind Pharm, 1-12.
37. Siepmann J, Peppas NA. (2001). Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev, 48:139-157. (Pubitemid 32434400)
38. Boateng JS, Matthews KH, Auffret AD, Humphrey MJ, Eccleston GM, Stevens HN. (2012). Comparison of the in vitro release characteristics of mucosal freeze-dried wafers and solventcast films containing an insoluble drug. Drug Dev Ind Pharm, 38:47-54.